课题基金 / 基金详情

Development of Cell Selective particle irradiation using epithermal neutron beam for malignant brain tumor.

Development of Cell Selective particle irradiation using epithermal neutron beam for malignant brain tumor.
使用超热中子束进行细胞选择性粒子照射治疗恶性脑肿瘤的进展。
批准号:
17390390
负责人:
MATSUMURA Akira
金额:
$10.12万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2005
资助国家:
日本
项目状态:
已结题
起止时间:
2005 至 2007

项目摘要

项目成果

MATSUMURA Akira的其他基金

相似基金

相关文献

中文摘要
翻译
8例经组织学证实的胶质母细胞瘤患者,平均年龄65岁(男:女=2:6,32~76岁),采用BNCT后加30GyX射线照射的新方案行BNCF。7例术前行BNCT治疗。15例中5例存活,术后平均随访20.3个月。进展时间11.9个月,总生存期25.3个月。不良反应(3~GT;级)2例,惊厥、脑肿胀1例,一过性动眼神经麻痹1例。为了估计组织中硼化合物的绝对浓度,用质子磁共振波谱(MRS)对苯丙氨酸和L-对硼苯丙氨酸进行了定量。我们可以识别几个特征共振,峰在7.32ppm(苯丙氨酸),四个峰在7.1ppm到7.6ppm(BPA)。使用水模体,以组织水信号为内标,通过质子磁共振波谱获得绝对浓度。基于MRS计算的浓度与已知浓度之间具有较高的相关性。(r=0.99:苯丙氨酸和双酚A)。这些临床结果似乎令人鼓舞,但侵袭性肿瘤细胞的有效性仍不清楚。改进的肿瘤靶向、硼输送和中子分布将提高BNCT的治疗效果。磁共振波谱结果表明,质子MRS可以作为BNCT中BPA定量的非侵入性和潜在有用的技术。
英文摘要
Clinical trial of BNCT for GlioblastomaEight patients with histological proven glioblastoma with an average age of 65 years (range 32-76, M:F=2:6) were underwent BNCF with new protocol which add 30Gy X ray irradiation after BNCT. 7 patients were treated with intra-operative BNCT before the protocol. In these 15 cases, 5 cases are alive; the average post BNCT follow up period was 20.3 months. Time to progression was 11.9 months, overall survival was 25.3 months. Adverse event (Grade 3>) were seen in 2 cases; convulsion and brain swelling (1 case) and transient oculomotor palsy (1 case). These result superior to standard treatments and suggest the effectiveness of the BNCT for malignant gliomaMR spectroscopyFor estimating absolute concentration of boron compounds in tissue, proton MR spectroscopy (MRS) was applied to quantify phenylalanine and L-p-boronophenylalanine (BPA). We could identify several characteristic resonances, peak of 7.32ppm (phenylalanine), four peak ranged 7.1 ppm to 7.6 ppm (BPA). A water phantom were used, and absolute concentration were obtained by proton MRS using a tissue water signal as an internal standards. These methods have high correlation between the calculated concentrations based on MRS and the known concentration. (R=0.99: phenylalanine and BPA).These clinical results appear to encouraging, but the effectiveness of the invading tumor cells are still unclear. Improved tumor targeting boron delivery and neutron distribution will enhance the therapeutic effectiveness of BNCT.MR spectroscopy results indicate that proton MRS can be non-invasive and potentially useful technique for BPA quantification in BNCT.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Dosimetry for Neutron capture Therapy in JRR-4
JRR-4 中子俘获疗法的剂量测定
DOI: --
发表时间: 2007
期刊: Japanese Journal of Health Physics 4281
影响因子: --
作者: [Kumada H, Yamamoto T]
通讯作者: Yamamoto T
Histopathological evaluation of glioblastoma after high-dose radiation therapy
高剂量放射治疗后胶质母细胞瘤的组织病理学评估
DOI: --
发表时间: 2007
期刊:
影响因子: --
作者: [Tsurubuchi T, Yamamoto T, Enomoto T, Sato M, Sakamoto N, Matsuda M, Marushima A, Nakai K, Saito A, Shibata Y, Tsuboi K, Matsumura. A]
通讯作者: Matsumura. A
Effects of combined treatment using sodium borocaptate(BSH) and buthionine sulfoximide(BSO) in a rat tumor model
硼己酸钠(BSH)与丁硫氨酸亚磺酰亚胺(BSO)联合治疗大鼠肿瘤模型的效果
DOI: --
发表时间: 2006
期刊:
影响因子: --
作者: [Fumiyo Yoshida, Tetsuya Yamamoto, Kei Nakai, Yasushi Shibata, Akira Matsumura]
通讯作者: Akira Matsumura
Proton MR spectroscopy for quantification of 1-phenylalanine
用于 1-苯丙氨酸定量的质子磁共振波谱
DOI: --
发表时间: 2007
期刊:
影响因子: --
作者: [Yamamoto Y, Isobe T, Anno I, Yamamoto T, Shibata Y, Matsumura A]
通讯作者: Matsumura A
31
    Basic research of anti-malignant tumor effect using fullerene particles and neutron capture reaction.
    • 批准号:
      24659643
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.41万
    • 财政年份:
      2012
    • 负责人:
      MATSUMURA Akira
    • 依托单位:
    Development of boronated peptide using anti-oxidative effect for neutron capture therapy
    • 批准号:
      21659337
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.2万
    • 财政年份:
      2009
    • 负责人:
      MATSUMURA Akira
    • 依托单位:
    Cell selective particle therapy for malignant brain tumor
    • 批准号:
      20390379
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $12.31万
    • 财政年份:
      2008
    • 负责人:
      MATSUMURA Akira
    • 依托单位:
    Investigation of molecular mechanism in bone regeneration
    • 批准号:
      19791043
    • 项目类别:
      Grant-in-Aid for Young Scientists (B)
    • 资助金额:
      $2.38万
    • 财政年份:
      2007
    • 负责人:
      MATSUMURA Akira
    • 依托单位:
    国内基金
    海外基金
    新型靶向硼药的研发及BNCT联合CAR-T治疗策略探索
    基于多模态影像与语义引导的BNCT 快速精准剂量计算新方法及关 键技术研究
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2024
    • 负责人:
      田锋
    • 依托单位:
    利用PET显像构建靶向肿瘤细胞αvβ6与肿瘤间质FAPα“二维 ”载硼药物用于胰腺癌BNCT治疗
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      30.0万元
    • 批准年份:
      2024
    • 负责人:
      黄顺
    • 依托单位:
    面向BNCT中子束流监测的高性能GEM中子谱仪关键技术研究
    • 批准号:
      12375297
    • 项目类别:
      面上项目
    • 资助金额:
      53万元
    • 批准年份:
      2023
    • 负责人:
      胡志猛
    • 依托单位: